Astrocyte Pharmaceuticals
CompanyUnited States· Biotech
US biotech developing treatments for brain injury.
Minutes holds 1 development and 1 deal naming Astrocyte Pharmaceuticals, recorded from September 2026.
Intelligence
Investors in rounds covered by Minutes
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Astrocyte PharmaceuticalsBiotech | FundingSeries B | $9.5M | Led by DeepWork CapitalWith MintPharma Capital, Waterstar Capital +2 | 30 Sep | Closed |